Arkema SA (OTCMKTS:ARKAY) Sees Large Drop in Short Interest

Arkema SA (OTCMKTS:ARKAY) was the target of a significant drop in short interest during the month of December. As of December 15th, there was short interest totaling 1,412 shares, a drop of 83.6% from the November 30th total of 8,603 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 28,506 shares, the short-interest ratio is currently 0.0 days. Based on an average daily trading volume, of 28,506 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

Arkema Trading Down 0.1%

Shares of OTCMKTS:ARKAY opened at $59.96 on Thursday. The company has a market capitalization of $4.56 billion, a PE ratio of 28.83, a PEG ratio of 1.13 and a beta of 0.90. Arkema has a 12-month low of $56.28 and a 12-month high of $91.51. The business has a 50 day moving average of $59.92 and a two-hundred day moving average of $66.33. The company has a current ratio of 3.07, a quick ratio of 2.26 and a debt-to-equity ratio of 0.55.

Arkema (OTCMKTS:ARKAY) last posted its earnings results on Friday, November 7th. The basic materials company reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.98 by $0.21. Arkema had a net margin of 1.55% and a return on equity of 5.15%. The firm had revenue of $2.52 billion during the quarter, compared to analysts’ expectations of $2.50 billion. As a group, analysts forecast that Arkema will post 8.36 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft lowered Arkema from a “buy” rating to a “hold” rating in a research note on Monday, November 24th. Zacks Research upgraded Arkema from a “strong sell” rating to a “hold” rating in a research note on Monday, December 8th. Citigroup reiterated a “buy” rating on shares of Arkema in a research report on Friday, October 3rd. Finally, Barclays lowered shares of Arkema from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 11th. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Arkema has a consensus rating of “Reduce”.

About Arkema

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.